¶ Satellite Glial Cells - Expanded
Satellite Glial Cells Expanded is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Satellite Glial Cells (SGCs) are specialized glial cells that ensheath neuronal cell bodies in peripheral ganglia, including dorsal root ganglia (DRG), trigeminal ganglia, and autonomic ganglia. These cells play crucial roles in sensory processing, pain transmission, and ganglion homeostasis.
- Location: Surround neuronal soma in peripheral ganglia
- Shape: Flattened, envelope-like cells
- Coverage: Each neuron typically covered by 1-3 SGC layers
- Gap junctions: Connect SGCs for communication
- Glutamine synthetase (GS): Glial marker
- S100β: Calcium-binding protein
- GFAP: Glial fibrillary acidic protein (upregulated in pathology)
- Connexin 43 (Cx43): Gap junction protein
- GLT-1: Glutamate transporter
- Kir4.1: Potassium channel
- Metabolic support: Provide energy substrates to neurons
- Ion homeostasis: Regulate extracellular K+ and glutamate
- Water balance: Maintain osmotic equilibrium
- Nutrient supply: Transport glucose and lactate
- Perineuronal barrier: Separate neuronal microenvironment
- Molecular filtering: Regulate substance exchange
- Immune protection: Shield neurons from immune cells
- Glutamate clearance: Prevent excitotoxicity
- K+ buffering: Regulate neuronal excitability
- ATP metabolism: Convert ATP to adenosine
- Nerve injury: SGCs proliferate and become reactive
- Inflammatory pain: Pro-inflammatory cytokine release
- Neuropathic pain: Gap junction coupling increases
- Migraine: Trigeminal ganglion SGC involvement
- Metabolic dysfunction: Glucose transport impairment
- Oxidative stress: Increased ROS production
- K+ dysregulation: Altered channel expression
- Drug uptake: Some chemotherapeutics target SGCs
- Support loss: Neuronal dysfunction secondary to SGC changes
- Sensory ganglia involvement: Some ALS forms
- Autonomic dysfunction: Autonomic ganglion changes
- Upregulation of GFAP: Reactive gliosis
- Increased Cx43: Enhanced coupling
- Cytokine production: IL-1β, TNF-α, IL-6
- ATP release: P2X7 receptor activation
- Kir4.1 downregulation: K+ buffering impairment
- TRPV1 sensitization: Pain pathway activation
- P2X7 receptor: ATP-gated ion channel
- Gap junction blockers: Carbenoxolone
- P2X7 antagonists: Emerging targets
- Cytokine modulators: Anti-inflammatory approaches
- SGC-derived factors in blood/CSF
- GFAP levels: Activation marker
- Cytokine profiles: Inflammatory state
| Condition |
SGC Changes |
| Chronic pain |
Proliferation, GFAP increase |
| Diabetic neuropathy |
Metabolic dysfunction |
| Migraine |
Trigeminal SGC activation |
| Neurodegeneration |
Variable involvement |
The study of Satellite Glial Cells Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hanani, Satellite glial cells in sensory ganglia (2005)
- Huang et al., Satellite glial cells in neuropathic pain (2020)
- Vit et al., Gap junctions in satellite glial cells (2008)
- Jager & Rich, Satellite glial cells in peripheral neuropathy (2021)